Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances [publication] /
by
Sedefov, Roumen [drt]
; Gallegos, Ana [drt]; European Monitoring Centre for Drugs and Drug Addiction.
Material type: 
BookSeries: EMCDDA Risk Assessments ; Nr. 9.Publisher: Luxembourg : The Publications Office of the Eurpean Union, 2011Description: 193 p.ill. : ill. ; 21 cm.ISBN: 9789291684571; 9291684570.SAPHIR theme(s): AddictionsMeSH subject(s): Substance-Related Disorders | Designer Drugs | Public Health | Risk AssessmentAddiction suisse subject(s): Designer Drogen | Risiko | UebersichtarbeitPUBLICATION TYPE SAPHIR: ReportOnline resources: Date de consultation : 23.05.2011 Summary: This publication presents the summary findings and the conclusions of the risk assessment on mephedrone, carried out by the EMCDDA's extended Scientific Committee, with participation of additional experts from the European Commission, Europol and the EMA. The risk assessment report, which was submitted to the European Commission and the Council of the European Union 26 May 2010, examines the health and social risks of the drug, as well as information on international trafficking and the involvement of organised crime. Furthermore, the report considers the potential implications for placing the drug under control in the EU. On the basis of this report and on the initiative of the European Commission on 2 December 2010, the Council decided that mephedrone is to be subject to control measures.
| Item type | Current location | Call number | Status | Date due |
|---|---|---|---|---|
| Addiction Suisse; Bibliothèque Bibliothèque | EMCDDA-65 (Browse shelf) | Available | ||
| Addiction Suisse; Bibliothèque | EMCDDA-65-1e (Browse shelf) | Available |
This publication presents the summary findings and the conclusions of the risk assessment on mephedrone, carried out by the EMCDDA's extended Scientific Committee, with participation of additional experts from the European Commission, Europol and the EMA. The risk assessment report, which was submitted to the European Commission and the Council of the European Union 26 May 2010, examines the health and social risks of the drug, as well as information on international trafficking and the involvement of organised crime. Furthermore, the report considers the potential implications for placing the drug under control in the EU. On the basis of this report and on the initiative of the European Commission on 2 December 2010, the Council decided that mephedrone is to be subject to control measures.